Literature DB >> 19807722

Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle.

P Bech1.   

Abstract

OBJECTIVE: To consider applied psychometrics in psychiatry as a discipline focusing on pharmacopsychology rather than psychopharmacology as illustrated by the pharmacopsychometric triangle.
METHOD: The pharmacopsychological dimensions of clinically valid effects of drugs (antianxiety, antidepressive, antimanic, and antipsychotic), of clinically unwanted effects of these drugs, and the patients' own subjective perception of the balance between wanted and unwanted effects are analysed using rating scales assessed by modern psychometric tests (item response theory models)
RESULTS: Symptom rating scales fulfilling the item response theory models have been shown to be psychometrically valid outcome scales as their total scores are sufficient statistics for demonstrating dose-response relationship within the various classes of antianxiety, antidepressive, antimanic or antipsychotic drugs. The total scores of side-effect rating scales are, however, not sufficient statistics, implying that each symptom has to be analysed individually. Self-rating scales with very few items appear to be sufficient statistics when measuring the patients' own perception of quality of life.
CONCLUSION: Applied psychometrics in psychiatry have been found to cover a pharmacopsychometric triangle illustrating the measurements of wanted and unwanted effects of pharmacotherapeutic drugs as well as health-related quality of life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807722     DOI: 10.1111/j.1600-0447.2009.01445.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

1.  Subjective positive well-being.

Authors:  Per Bech
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

Review 2.  Overview of measurement-based positive psychiatry.

Authors:  Graham M L Eglit; Barton W Palmer; Dilip V Jeste
Journal:  Nord J Psychiatry       Date:  2018-08       Impact factor: 2.202

3.  Dimensional and hierarchical models of depression using the Beck Depression Inventory-II in an Arab college student sample.

Authors:  Fawziyah A Al-Turkait; Jude U Ohaeri
Journal:  BMC Psychiatry       Date:  2010-07-29       Impact factor: 3.630

4.  The Pharmacopsychometric Triangle to Illustrate the Effectiveness of T-PEMF Concomitant with Antidepressants in Treatment Resistant Patients: A Double-Blind, Randomised, Sham-Controlled Trial Revisited with Focus on the Patient-Reported Outcomes.

Authors:  P Bech; M Gefke; M Lunde; L Lauritzen; K Martiny
Journal:  Depress Res Treat       Date:  2011-06-07

5.  From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings.

Authors:  Konstantinos N Fountoulakis; Roger S McIntyre; André F Carvalho
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

6.  The challenge of measurement in psychiatry: the lifetime accomplishments of Per Bech (1942-2018).

Authors:  Marcelo P Fleck; Danilo Carrozzino; Giovanni A Fava
Journal:  Braz J Psychiatry       Date:  2019-10-17       Impact factor: 2.697

7.  DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression-a randomised clinical trial.

Authors:  Jesper Krogh; Poul Videbech; Carsten Thomsen; Christian Gluud; Merete Nordentoft
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

8.  Eysenck's Two Big Personality Factors and Their Relationship to Depression in Patients with Chronic Idiopathic Pain Disorder: A Clinimetric Validation Analysis.

Authors:  Per Bech; Marianne Lunde; Stine Bjerrum Møller
Journal:  ISRN Psychiatry       Date:  2012-09-04

9.  No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.

Authors:  Konstantinos N Fountoulakis; Areti Angeliki Veroniki; Melina Siamouli; Hans-Jürgen Möller
Journal:  Ann Gen Psychiatry       Date:  2013-08-13       Impact factor: 3.455

10.  Family psychoeducation for major depressive disorder - study protocol for a randomized controlled trial.

Authors:  Nina Timmerby; Stephen F Austin; Kristian Ussing; Per Bech; Claudio Csillag
Journal:  Trials       Date:  2016-08-30       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.